(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(1.45%) $922.85
(0.04%) $0.927
(0.07%) $10.85
(0.02%) $0.792
(-0.03%) $92.55
Live Chart Being Loaded With Signals
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China...
Stats | |
---|---|
Today's Volume | 736 500 |
Average Volume | 264 468 |
Market Cap | 2.66B |
EPS | HKD0 ( 2023-08-25 ) |
Last Dividend | HKD0.360 ( 2023-06-16 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 7.06 |
ATR14 | HKD0.0160 (0.44%) |
Golden Throat Holdings Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Golden Throat Holdings Correlation - Currency/Commodity
Golden Throat Holdings Financials
Annual | 2022 |
Revenue: | HKD992.01M |
Gross Profit: | HKD720.92M (72.67 %) |
EPS: | HKD0.380 |
Q2 | 2023 |
Revenue: | HKD479.65M |
Gross Profit: | HKD362.12M (75.50 %) |
EPS: | HKD0.170 |
Q4 | 2022 |
Revenue: | HKD679.90M |
Gross Profit: | HKD493.85M (72.64 %) |
EPS: | HKD0.300 |
Q2 | 2022 |
Revenue: | HKD312.11M |
Gross Profit: | HKD227.07M (72.75 %) |
EPS: | HKD0.0767 |
Financial Reports:
No articles found.
Golden Throat Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.360 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0600 | 2016-05-26 |
Last Dividend | HKD0.360 | 2023-06-16 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 10 | -- |
Total Paid Out | HKD1.140 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.62 | -- |
Div. Sustainability Score | 8.21 | |
Div.Growth Potential Score | 5.25 | |
Div. Directional Score | 6.73 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
3833.HK | Ex Dividend Junior | 2023-06-02 | Sporadic | 0 | 0.00% | |
1731.HK | Ex Dividend Junior | 2023-06-23 | Sporadic | 0 | 0.00% | |
0778.HK | Ex Dividend Junior | 2023-08-23 | Semi-Annually | 0 | 0.00% | |
2317.HK | Ex Dividend Junior | 2023-09-14 | Annually | 0 | 0.00% | |
1299.HK | Ex Dividend Knight | 2023-09-08 | Semi-Annually | 0 | 0.00% | |
0371.HK | Ex Dividend Junior | 2023-06-12 | Semi-Annually | 0 | 0.00% | |
6078.HK | Ex Dividend Junior | 2023-06-30 | Annually | 0 | 0.00% | |
1857.HK | Ex Dividend Junior | 2023-08-23 | Semi-Annually | 0 | 0.00% | |
0883.HK | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
0034.HK | Ex Dividend Knight | 2023-12-15 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.299 | 1.500 | 4.02 | 6.03 | [0 - 0.5] |
returnOnAssetsTTM | 0.177 | 1.200 | 4.09 | 4.91 | [0 - 0.3] |
returnOnEquityTTM | 0.234 | 1.500 | 8.52 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.713 | -1.000 | 2.87 | -2.87 | [0 - 1] |
currentRatioTTM | 2.78 | 0.800 | 1.085 | 0.868 | [1 - 3] |
quickRatioTTM | 2.15 | 0.800 | 2.06 | 1.647 | [0.8 - 2.5] |
cashRatioTTM | 1.701 | 1.500 | 1.659 | 2.49 | [0.2 - 2] |
debtRatioTTM | 0.133 | -1.500 | 7.78 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.546 | 2.00 | 9.82 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.526 | 2.00 | 9.74 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.183 | -1.500 | 9.27 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.738 | 1.000 | 1.030 | 1.030 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.385 | 1.000 | 4.30 | 4.30 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.546 | 1.000 | 2.52 | 2.52 | [0.2 - 2] |
assetTurnoverTTM | 0.593 | 0.800 | 9.38 | 7.51 | [0.5 - 2] |
Total Score | 8.21 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 7.28 | 1.000 | 9.37 | 0 | [1 - 100] |
returnOnEquityTTM | 0.234 | 2.50 | 9.05 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.526 | 2.00 | 9.82 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 10.54 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.546 | 2.00 | 9.82 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.713 | 1.500 | 2.87 | -2.87 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.348 | 1.000 | 3.80 | 0 | [0.1 - 0.5] |
Total Score | 5.25 |
Golden Throat Holdings
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China. It offers Golden Throat lozenges over-the-counter medicine to relive symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat lozenge series products that include Dule lozenges and sugar-free Dule lozenges in various flavors, such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn; Yinxingye tablet, which is designed to facilitate blood circulation, remove blood stasis, and dredge energy channels; and herbal vegetable beverages for soothing voice and relieving sore throats. The company also exports its products to the United States, Canada, Russia, the European Union, Australia, Southeast Asia, the Middle East, Mexico, and Africa. Golden Throat Holdings Group Company Limited was founded in 1956 and is headquartered in Liuzhou, the People's Republic of China.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators